Search Results
Search for other papers by Miguel A Zaballos in
Google Scholar
PubMed
Search for other papers by Pilar Santisteban in
Google Scholar
PubMed
variant (TCV-PTC). PTC is mostly related to mutations that activate the MAPK (mitogen-activated protein kinase) signaling pathway, such as RET , NTRK (neurotrophic receptor tyrosine kinase) and ALK (anaplastic lymphoma kinase) gene rearrangements or
Search for other papers by Y L Bao in
Google Scholar
PubMed
Search for other papers by K Tsuchida in
Google Scholar
PubMed
Search for other papers by B Liu in
Google Scholar
PubMed
Search for other papers by A Kurisaki in
Google Scholar
PubMed
Search for other papers by T Matsuzaki in
Google Scholar
PubMed
Search for other papers by H Sugino in
Google Scholar
PubMed
interfered with TH promoter activation by activin A and bFGF (Fig. 7D ). These data indicate the important role of the Smad signaling pathway for TH regulation by activin A and bFGF. Activation of ERK1/2 MAPK is required for the
Search for other papers by G Almeida-Pereira in
Google Scholar
PubMed
Search for other papers by T Vilhena-Franco in
Google Scholar
PubMed
Search for other papers by R Coletti in
Google Scholar
PubMed
Search for other papers by S Q Cognuck in
Google Scholar
PubMed
Search for other papers by H V P Silva in
Google Scholar
PubMed
Search for other papers by L L K Elias in
Google Scholar
PubMed
Search for other papers by J Antunes-Rodrigues in
Google Scholar
PubMed
phospholipase C, protein kinase C (PKC) and members of the mitogen-activated protein kinase family (MAPK; extracellular signal-regulated kinases 1 and 2 (ERK1/2), p38MAPK and c-Jun N-terminal Kinase (JNK)) ( Mehta & Griendling 2007 ). MAPK proteins are
Laboratoire de Biologie de la Differentation et du Development, Universite Victor Segalen Bordeaux 2, 146 rue Leo Saignat 33076 Bordeaux cedex, France
Search for other papers by A G Kayali in
Google Scholar
PubMed
Laboratoire de Biologie de la Differentation et du Development, Universite Victor Segalen Bordeaux 2, 146 rue Leo Saignat 33076 Bordeaux cedex, France
Search for other papers by A Stotland in
Google Scholar
PubMed
Laboratoire de Biologie de la Differentation et du Development, Universite Victor Segalen Bordeaux 2, 146 rue Leo Saignat 33076 Bordeaux cedex, France
Search for other papers by K V Gunst in
Google Scholar
PubMed
Laboratoire de Biologie de la Differentation et du Development, Universite Victor Segalen Bordeaux 2, 146 rue Leo Saignat 33076 Bordeaux cedex, France
Search for other papers by M Kritzik in
Google Scholar
PubMed
Laboratoire de Biologie de la Differentation et du Development, Universite Victor Segalen Bordeaux 2, 146 rue Leo Saignat 33076 Bordeaux cedex, France
Search for other papers by G Liu in
Google Scholar
PubMed
Laboratoire de Biologie de la Differentation et du Development, Universite Victor Segalen Bordeaux 2, 146 rue Leo Saignat 33076 Bordeaux cedex, France
Search for other papers by S Dabernat in
Google Scholar
PubMed
Laboratoire de Biologie de la Differentation et du Development, Universite Victor Segalen Bordeaux 2, 146 rue Leo Saignat 33076 Bordeaux cedex, France
Search for other papers by Y-Q Zhang in
Google Scholar
PubMed
Laboratoire de Biologie de la Differentation et du Development, Universite Victor Segalen Bordeaux 2, 146 rue Leo Saignat 33076 Bordeaux cedex, France
Search for other papers by W Wu in
Google Scholar
PubMed
Laboratoire de Biologie de la Differentation et du Development, Universite Victor Segalen Bordeaux 2, 146 rue Leo Saignat 33076 Bordeaux cedex, France
Search for other papers by N Sarvetnick in
Google Scholar
PubMed
activated, after which they can activate MAPK ( Bonfini et al. 1996 , Schlessinger 2000 ). Another major signaling pathway activated by growth factors, the PI3 kinase pathway phosphorylates phosphatidylinositols, yielding lipid products that bind the
Search for other papers by Jodie M Fleming in
Google Scholar
PubMed
Search for other papers by Jeffrey A Brandimarto in
Google Scholar
PubMed
Search for other papers by Wendie S Cohick in
Google Scholar
PubMed
regulation of these two IGFBP by IGF-I via analysis of intracellular signaling pathways. In the present study, we found that both the PI3K and the MAPK pathways were required for IGF-I to increase IGFBP-3 and -5 in MF. However, an unexpected and
Search for other papers by Juliana I Candelaria in
Google Scholar
PubMed
Search for other papers by Maria B Rabaglino in
Google Scholar
PubMed
Search for other papers by Anna C Denicol in
Google Scholar
PubMed
against p44/42 MAPK (4695, Cell Signaling Technology) or a rabbit isotype IgG overnight in a humidified chamber at 4°C. After washing, 1 µg/mL FITC-conjugated donkey anti-rabbit secondary antibody was added for 1 h at RT, followed by 10 min incubation with
Millennium Institute for Fundamental and Applied Biology, Santiago, Chile
Search for other papers by Pedro A Orihuela in
Google Scholar
PubMed
Millennium Institute for Fundamental and Applied Biology, Santiago, Chile
Search for other papers by Alexis Parada-Bustamante in
Google Scholar
PubMed
Millennium Institute for Fundamental and Applied Biology, Santiago, Chile
Search for other papers by Lidia M Zuñiga in
Google Scholar
PubMed
Millennium Institute for Fundamental and Applied Biology, Santiago, Chile
Search for other papers by Horacio B Croxatto in
Google Scholar
PubMed
and MAPK signalling cascades in this nongenomic pathway. First we examined the role of IP3 and MAPK on accelerated oocyte transport induced by E 2 . The effect of E 2 on the levels of IP3 or phosphorylated MAPK p44/42 in the rat oviduct was then
Search for other papers by Danielle Brown in
Google Scholar
PubMed
Search for other papers by Amiya P Sinha Hikim in
Google Scholar
PubMed
Search for other papers by Ekaterina L Kovacheva in
Google Scholar
PubMed
Search for other papers by Indrani Sinha-Hikim in
Google Scholar
PubMed
Notch signaling in T-mediated muscle fiber hypertrophy. Mitogen-activated protein kinases (MAPKs) comprise a family of serine/threonine kinases that function as critical mediators of variety of extracellular signals ( Johnson & Lapadat 2002 , Wada
Search for other papers by Helena C Barbosa in
Google Scholar
PubMed
Search for other papers by Silvana Bordin in
Google Scholar
PubMed
Search for other papers by Gabriel Anhê in
Google Scholar
PubMed
Search for other papers by Shanta J Persaud in
Google Scholar
PubMed
Search for other papers by James Bowe in
Google Scholar
PubMed
Search for other papers by Maria I Borelli in
Google Scholar
PubMed
Search for other papers by Juan J Gagliardino in
Google Scholar
PubMed
Search for other papers by Antonio C Boschero in
Google Scholar
PubMed
-154), and anti-phospho MAPK3/1 -Thr202/Tyr204 (mouse monoclonal sc-7383) antibodies were from Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA; and anti-phospho P70S6K -Thr389 (mouse polyclonal, #9206S) was from Cell Signaling Technology Inc
Search for other papers by Kotaro Horiguchi in
Google Scholar
PubMed
Search for other papers by Ken Fujiwara in
Google Scholar
PubMed
Search for other papers by Cimi Ilmiawati in
Google Scholar
PubMed
Search for other papers by Motoshi Kikuchi in
Google Scholar
PubMed
Search for other papers by Takehiro Tsukada in
Google Scholar
PubMed
Search for other papers by Tom Kouki in
Google Scholar
PubMed
Search for other papers by Takashi Yashiro in
Google Scholar
PubMed
and cyclin D1 production, which suggests that integrin β1 receives laminin as a signal on FS cells and that its signaling activates MAPK signaling cascades, leading to cyclin D1 transcription and contributing to cell cycle progression. However, there